Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03890419 · ClinicalTrials.gov registry record · NA
Opioid Sparing Potential of Light-Induced Analgesia
A NA study, sponsored by Duke University.
- Completed
- Registry status
- NA
- Development phase
- 94
- Enrollment target
NCT03890419 is a NA study that has completed, run by Duke University. The registered enrollment target is 94 participants.
The verdict
NCT03890419, a NA study, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- NA
- Development phase
- 94 participants
- Enrollment target
Study Summary
This is a pilot trial testing the potential opioid-sparing analgesic effect of a novel non-pharmacological treatment using visualized light spectrums. Preclinical findings have shown such treatments to alter pain perception.
Interventions
- DEVICE Blue Light
- DEVICE Green light
- DEVICE Clear light
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 94 participants |
| Start Date | 2019-06-17 |
| Est. Completion | 2021-03-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03890419
The ClinicalTrials.gov registry entry for NCT03890419 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 94 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Blue Light is the first listed.
NCT03890419 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03890419 about?
NCT03890419 is a clinical study titled "Opioid Sparing Potential of Light-Induced Analgesia". This is a pilot trial testing the potential opioid-sparing analgesic effect of a novel non-pharmacological treatment using visualized light spectrums. Preclinical findings have shown such treatments to alter pain perception.
What is the current status of trial NCT03890419?
This trial is currently completed. It is a NA study. The enrollment target is 94 participants. The study started on 2019-06-17. Estimated completion is 2021-03-31.
What interventions are being tested in trial NCT03890419?
The interventions under investigation include: Blue Light (DEVICE), Green light (DEVICE), Clear light (DEVICE).
Who is sponsoring clinical trial NCT03890419?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.